Kumar Budur, Chief Medical Officer at Harmony Biosciences, sold HRMY on Sep 18, 2026
Data as of Oct 16
▼ SELL$1.5M35,852 shares at $43.05Kumar Budur Chief Medical OfficerHRMY Harmony Biosciences Holdings, Inc.
- Traded
- Sep 18, 2026
- Disclosed
- Sep 18, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
HRMY since disclosure
−9.7%
after the sale
Similar stocks (XLV) since disclosure
+4.9%
XLV — its sector index fund
Change in closing price from Sep 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLKumar Budur Chief Medical OfficerHRMY Harmony Biosciences Holdings, Inc.$34.4Kdisclosed Sep 18 · filed 1 day after the trade
- ▼ SELLKumar Budur Chief Medical OfficerHRMY Harmony Biosciences Holdings, Inc.$77.4Kdisclosed Sep 18 · filed 2 days after the trade